VIDA Diagnostics

VIDA Diagnostics is an AI-powered clinical trial imaging and digital biomarker company that specializes in accelerating drug development and clinical trial adoption through data-driven imaging analytics. The company operates the VIDA Intelligence Platform, which enables pharmaceutical sponsors to collect, manage, and leverage high-quality imaging data throughout the drug development lifecycle. VIDA provides comprehensive clinical trial imaging services including AI-powered digital biomarker generation, radiology assessments (eligibility reads, safety reads, adjudication), site management and training, and trial orchestration dashboards. The platform generates quantitative imaging biomarkers across multiple therapeutic areas including respiratory diseases (COPD, asthma, ILD/IPF, cystic fibrosis), cardiovascular conditions (coronary artery disease, pulmonary hypertension, pulmonary embolism), oncology, neurology, musculoskeletal, and gastroenterology. VIDA maintains a digital biobank comprising over 500,000 patients, 500TB+ of multi-omic data, and 1B+ biological metrics, enabling advanced analytics such as external control arm creation, digital twin modeling, and retrospective biomarker discovery. The company is HIPAA-compliant, ISO 13485:2016 certified, and employs AES-256 encryption for data security.